Cargando…
Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders
Zellweger spectrum disorders (ZSDs), a subgroup of peroxisomal biogenesis disorders, have a generalized defect in peroxisome function. Liver disease in ZSDs has been linked to accumulation of C(27)-bile acid intermediates due to the lack of peroxisomal β-oxidation of these intermediates to form prim...
Autores principales: | Heubi, James E., Setchell, Kenneth D.R., Bove, Kevin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062720/ https://www.ncbi.nlm.nih.gov/pubmed/30057520 http://dx.doi.org/10.1159/000490095 |
Ejemplares similares
-
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2017) -
Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder
por: Heubi, James E., et al.
Publicado: (2018) -
Cholic acid therapy in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2016) -
Cholbam® and Zellweger spectrum disorders: treatment implementation and management
por: Anderson, Janaina Nogueira, et al.
Publicado: (2021) -
High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2014)